Societal CDMO Inc
NASDAQ:SCTL
Societal CDMO Inc
NASDAQ:SCTL
Price:
1.1 USD
Market Closed
Updated:
May 29, 2024
Societal CDMO Inc
Additional Paid In Capital
|
Societal CDMO Inc
Additional Paid In Capital Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Societal CDMO Inc
NASDAQ:SCTL
|
Additional Paid In Capital
$336.5m
|
CAGR 3-Years
15%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Additional Paid In Capital
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Additional Paid In Capital
$45.7B
|
CAGR 3-Years
1%
|
CAGR 5-Years
85%
|
CAGR 10-Years
41%
|
|
|
Pfizer Inc
NYSE:PFE
|
Additional Paid In Capital
$93B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Additional Paid In Capital
$44.6B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
1%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Additional Paid In Capital
$7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
See Also
What is Societal CDMO Inc's Additional Paid In Capital?
Additional Paid In Capital
336.5m
USD
336.5m
USD
Based on the financial report for Dec 31, 2023, Societal CDMO Inc's Additional Paid In Capital amounts to 336.5m USD.
What is Societal CDMO Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
15%
15%
Over the last year, the Additional Paid In Capital growth was 5%. The average annual Additional Paid In Capital growth rates for Societal CDMO Inc have been 15% over the past three years , 15% over the past five years .
You don't have any saved screeners yet
